Role(s) in Healthcare Innovation:

Entrepreneur

Erik A MUNSON, MS

Founder

Solver Medical

Minnetrista, Minnesota United States


Biotechnology, Greater Minneapolis-St. Paul Area

About Me

I am a seasoned executive with over 16 years in the medical industry. I have several patents to my name and have brought innovation in both product development and marketing to each company I have worked with. I am excited to share my next Innovation to Medstartr with Solvere Company, a digital start up based in the heart of Medical Alley (Minneapolis/St. Paul, MN). I am passionate about bringing new technology to market that will dramatically improve the patients who we focus on. Outside of my professional passion, I am a very fortunate husband to my wife, Molly, and extremely proud parent to 4 wonderful children (Mackenzie, Matthew, Spencer, and Liam).

I am looking for healthcare innovations:

You have not backed any projects. Lets change that!
Discover Projects

No project created yet. Lets change that!
Discover Projects

No comments on any project yet. Lets change that!
Discover Projects

No likes on any project yet.. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No project reviewed yet. Lets change that!
Discover Projects

Important Disclosure: MedStartr.com is a website owned and operated by MedStartr, Inc., which is not a broker-dealer, funding portal or investment advisor; and neither the website nor MedStartr, Inc. participate in the offer or sale of securities. All securities related activity is conducted through Young America Capital, LLC, a registered broker-dealer and member of FINRA/SIPC. No communication, through this website, email or in any other medium, should be construed as a recommendation for any securities offering.